Usage of 5-fluorouracil to prevent excessive scarring after hypotensive operations of non-penetrating type

Written by Fedyashev G.A., Shellenberg P.V., Eliseeva E.V.

  UDK: 617.7–007.681–089.87–089.168.1–06–085.277.3 | Pages: 52–54 | Full text PDF | Open PDF 


Objective. The effectiveness of topical application of 5-fluorouracil after antiglaucoma operations for the prevention of scarring of the formed outflow pathways of the intraocular fluid was analyzed.
Methods. The study included 112 patients over 35 y.o. (125 eyes), operated for the primary open-angle glaucoma in the far-advanced stage in PCEM in 2015–2017. Patients were divided into two groups comparable in age, glaucoma stage, and pre-operation level of intraocular pressure (IOP): 1st group – 57 patients (63 eyes) were undergone non-penetrating deep sclerectomy with 5 % 5-fluorouracil; 2nd group – 55 patients (62 eyes) without 5-fluorouracil.
Results. On the 7th day after the operation there was the difference in IOP values between groups: when using antimetabolite they were significantly lower. On the 15th day the difference in values significantly increased, and this tendency persisted for six months. By the 9th months of observation average values of IOP in both groups was almost equal. In a year and a half there were two patients who did not need a laser descemetopuncture from the group used 5-fluorouracil, there were no such patients in the 2nd group.
Conclusions. Thus, the use of 5-fluorouracil in the form of injections is a safe way of preventing early scarring processes in the area of formed outflow pathways of the eye fluid, which significantly increases the effectiveness of antiglaucoma surgery.

Links to authors:

G.A. Fedyashev1, 2, P.V. Shellenberg1, E.V. Eliseeva1
1 Pacific State Medical University (2 Ostryakova Ave. Vladivostok 690002 Russian Federation),
2 Primorskiy Center of Eye Microsurgery (100e Borisenko St. Vladivostok 690080 Russian Federation)

1. Kuroyedov AV, Brezhnev A.Yu., Aleksandrov A.S., Ogorodnikov V.Yu. Principles of treatment of the initial stage of glaucoma: surgery against therapy (literature review) // Military Medical Journal. 2011. Vol. 332, No. 5. P. 28–35.
2. Petrov S.Yu. A modern concept of combating excess scarring after a fistulizing antiglaucoma operation. Risk factors and antimetabolic drugs // Ophthalmology. 2017. Vol. 14, No. 1. P. 5–11.
3. Petrov S.Yu. Modern concept of controlling excess scarring after fistulizing glaucoma surgery. Anti-inflammatory drugs and new tendencies // Ophthalmology. 2017. Vol. 14, No. 2. P. 99–105.
4. Petrov S.Yu., Antonov AA, Vostrukhin S.V. Activation of the filtration cushion in the early period after a fistulizing operation // Ophthalmology. 2014. Vol. 11, No. 3. P. 80–88.
5. Petrov S.Yu., Safonova D.M. The modern concept of excess scarring in glaucoma surgery // Ophthalmology. 2015. Vol. 12, No. 4. P. 9–16.
6. Khristin M., Erichev VP, Anisimova S.Yu. [et al.]. Combined system of preventing excessive scarring in glaucoma surgery // Glaukoma. 2010. No. 2. P. 16–18.
7. Amoozgar B, Lin S.C., Han Y., Kuo J. A role for antimetabolites in glaucoma tube surgery: current evidence and future directions // Curr. Opin. Ophthalmol. 2016. Vol. 27, No. 2. P. 164–169.
8. Mercieca K., Drury B., Bhargava A., Fenerty C. Trabeculectomy bleb needling and antimetabolite administration practices in the UK: A glaucomaspecialist national survey // Br. J. Ophthalmol. 2017. doi: 10.1136/bjophthalmol-2017-310812.
9. Lindemann F., Plange N., Kuerten D. [et al.]. Three-year follow-up of trabeculectomy with 5-fluorouracil // Ophthalmic Res. 2017. Vol. 58, No. 2. P. 74–80.
10. Wong M.H., Husain R., Ang B.C. [et al.]. The Singapore 5-fluorouracil trial: Intraocular pressure outcomes at 8 years // Ophthalmology. 2013. Vol. 120, No. 6. P. 1127–1134.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.